Please provide your email address to receive an email when new articles are posted on . Over the past decade, the frequency of aqueous shunt surgery has risen dramatically. Studies have shown us the ...
Cristina Bentin, principal, Coding Compliance Management: While there are a few potential codes utilized for the reporting of aqueous shunts and devices, Category III code 0192T (Insertion of anterior ...
Almost half of patients medication free at 12 months. Vast majority of patients achieved significant IOP reduction on the same or fewer medications. Strong 12-month safety and efficacy results: no ...
The multi‐site VITA trial, a prospective pilot study designed to assess the safety and effectiveness of Avisi Technologies' investigational VisiPlate® device, enrolled and treated 15 subjects (mean ...
The use of aqueous shunts for the management of refractory glaucoma is increasing compared with trabeculectomy. The number of shunts being placed increased 184% from 1995 to 2004. Commonly used ...
The investigational VisiPlate® aqueous shunt is Avisi Technologies' flagship "minimally invasive bleb surgery" (MIBS) device. Made from non-fibrotic nanotechnology-enabled metamaterials, it works by ...
CPT copyright 2009 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association. Q: We are receiving regular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results